Rocket


News + Filings
Transactions
Holdings



Manning Paul B

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
08/16/2023Taysha Gene Therapies, Inc. PurchaseCommon Stock16.5M$0.90$14.8MSee footnote08/16/2023
06/28/2023Candel Therapeutics, Inc. GrantStock Option (Right to Buy)14.2k$1.22$17.4k 06/28/2023
10/31/2022Taysha Gene Therapies, Inc. PurchaseCommon Stock1.5M$2.00$3M 10/31/2022
10/13/2022Candel Therapeutics, Inc. GrantStock Option (Right to Buy)14.2k$2.81$40k 10/13/2022
07/05/2022Verrica Pharmaceuticals Inc.VRCAPurchaseCommon Stock4.8M$2.10$10M 07/05/2022
06/17/2022Taysha Gene Therapies, Inc. GrantStock Option (right to buy)15.5k$2.81$43.6k 06/17/2022
06/17/2022Liquidia Corp GrantNon-Qualified Stock Option (right to buy)20k$4.86$97.2k 06/17/2022
04/18/2022Liquidia Corp PurchaseCommon Stock392.2k$5.10$2M 04/18/2022
03/31/2022Liquidia Corp GrantCommon Stock435.7k$0.00$0See footnote03/31/2022
02/03/2022Taysha Gene Therapies, Inc. PurchaseCommon Stock50k$7.84$392k 02/02/2022
02/03/2022Taysha Gene Therapies, Inc. PurchaseCommon Stock26.6k$7.84$208.6kSee footnote02/02/2022
02/02/2022Taysha Gene Therapies, Inc. PurchaseCommon Stock58k$7.77$450.7k 02/02/2022
02/02/2022Taysha Gene Therapies, Inc. PurchaseCommon Stock45k$7.77$349.6kSee footnote02/02/2022
02/02/2022Taysha Gene Therapies, Inc. PurchaseCommon Stock22k$7.77$170.9kSee footnote02/02/2022
12/03/2021Verrica Pharmaceuticals Inc.VRCAPurchaseCommon Stock20k$9.22$184.2k 12/02/2021
12/02/2021Verrica Pharmaceuticals Inc.VRCAPurchaseCommon Stock30k$9.45$283.7k 12/02/2021
11/24/2021Taysha Gene Therapies, Inc. PurchaseCommon Stock2.2k$13.19$29k 11/24/2021
11/23/2021Taysha Gene Therapies, Inc. PurchaseCommon Stock20k$12.54$250.8k 11/23/2021
08/20/2021Liquidia Corp GrantNon-Qualified Stock Option (right to buy)20k$2.59$51.8k 08/20/2021
07/29/2021Candel Therapeutics, Inc. ConversionCommon Stock679.2k$0.00$0By Paul B. Manning Revocable Trust07/29/2021
07/29/2021Candel Therapeutics, Inc. ConversionCommon Stock553.8k$0.00$0By BKB Growth Investments, LLC07/29/2021
07/29/2021Candel Therapeutics, Inc. PurchaseCommon Stock1.6M$8.00$13M 07/29/2021
07/29/2021Candel Therapeutics, Inc. ConversionSeries B Preferred Stock1.7M$0.00$0By Paul B. Manning Revocable Trust07/29/2021
07/29/2021Candel Therapeutics, Inc. ConversionSeries B Preferred Stock1.4M$0.00$0By BKB Growth Investments, LLC07/29/2021
07/29/2021Candel Therapeutics, Inc. ConversionCommon Stock679.2k$0.00$0By Paul B. Manning Revocable Trust07/29/2021
07/29/2021Candel Therapeutics, Inc. ConversionCommon Stock553.8k$0.00$0By BKB Growth Investments, LLC07/29/2021
07/29/2021Candel Therapeutics, Inc. ConversionSeries B Preferred Stock1.7M$0.00$0By Paul B. Manning Revocable Trust07/29/2021
07/29/2021Candel Therapeutics, Inc. ConversionSeries B Preferred Stock1.4M$0.00$0By BKB Growth Investments, LLC07/29/2021
07/29/2021Candel Therapeutics, Inc. PurchaseCommon Stock20k$7.30$145.9k 07/27/2021
07/27/2021Candel Therapeutics, Inc. PurchaseCommon Stock36k$7.36$264.8k 07/27/2021
07/06/2021Acumen Pharmaceuticals, Inc. ConversionCommon Stock3M$0.00$0See footnote07/06/2021
07/06/2021Acumen Pharmaceuticals, Inc. PurchaseCommon Stock312.5k$16.00$5MSee footnote07/06/2021
07/06/2021Acumen Pharmaceuticals, Inc. ConversionCommon Stock658k$0.00$0See footnote07/06/2021
07/06/2021Acumen Pharmaceuticals, Inc. ConversionSeries A-1 Preferred Stock1.6M$0.00$0See footnote07/06/2021
07/06/2021Acumen Pharmaceuticals, Inc. ConversionSeries B Preferred Stock1.3M$0.00$0See footnote07/06/2021
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy